1-5 of 5
Lamia Torjman
Close
Sort by
Journal Articles

Use of “high flow” Totally Implantable Central Venous Access Ports for Myeloablative Conditioning Followed by Allogeneic Stem Cell Transplantation: a Prospective Study.

Abderrahman Abdelkefi, Olfa Ben Gaied, Saloua Ladeb, Lamia Torjman, Amel Lakhal, Tarek Ben Othman
Journal: Blood
Blood (2009) 114 (22): 4648.
https://doi.org/10.1182/blood.V114.22.4648.4648
Published: 2009
Journal Articles

Catheter Related Bloodstream Infection in Haematological Patients: A Prospective, Randomized Study Comparing Heparin-Coated with Chlorhexidine and Silver Sulfadiazine Impregnated Central Venous Catheters

Abderrahman Abdelkefi, Mouna Chelli, Wafa Achour, Neila Ben Romdhane, Lamia Torjman, Saloua Ladeb, Amel Lakhal, Mohamed Hsairi, Hajer Kallel, Fathi Ladeb, Assia Ben Hassen, Tarek Ben Othman
Journal: Blood
Blood (2008) 112 (11): 1174.
https://doi.org/10.1182/blood.V112.11.1174.1174
Published: 2008
Journal Articles

Single autologous stem-cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma: results of a multicenter randomized clinical trial

Clinical Trials & Observations
Abderrahman Abdelkefi, Saloua Ladeb, Lamia Torjman, Tarek Ben Othman, Amel Lakhal, Neila Ben Romdhane, Halima El Omri, Moez Elloumi, Hatem Belaaj, Ramzi Jeddi, Lamia Aissaouï, Habib Ksouri, Assia Ben Hassen, Fahmi Msadek, Ali Saad, Mohamed Hsaïri, Kamel Boukef, Ahlem Amouri, Hechmi Louzir, Koussay Dellagi, Abdeladhim Ben Abdeladhim
Journal: Blood
Blood (2008) 111 (4): 1805–1810.
https://doi.org/10.1182/blood-2007-07-101212
Published: 2008
Includes: Supplemental data
Journal Articles

Gene Expression Profiling of Myeloma Cells To Predict Response to Primary Therapy with Thalidomide-Dexamethasone for Newly Diagnosed Multilple Myeloma.

Abderrahman Abdelkefi, MD, John de Vos, M.D, Said Assou, M.D, Tarek Ben Othman, M.D, Jean-Francois Rossi, M.D, Saloua Ladeb, M.D, Ines Safra, M.D, Yosr Galai, M.D, Malika Ben Ahmed, M.D, Alia Benkahla, M.D, Faouzi Jenhani, M.D, Moufida Ben Nasr, M.D, Lamia Torjman, M.D, Amel Lakhal, M.D, Hechmi Louzir, M.D, Abdeladhim Ben Abdeladhim, M.D
Journal: Blood
Blood (2007) 110 (11): 1494.
https://doi.org/10.1182/blood.V110.11.1494.1494
Published: 2007
Journal Articles

Timing of Second Autologous Transplantations in Multiple Myeloma: Results of a Multicenter Sequential Randomized Clinical Trial.

Abderrahman Abdelkefi, MD, Saloua Ladeb, MD, Tarek Ben Othman, MD, Lamia Torjman, MD, Amel Lakhal, MD, Neila Ben Romdhane, Halima El Omri, Moez Elloumi, Hatem Bellaj, Ramzi Jeddi, Lamia Aissaoui, Fahmi Msadek, Ali Saad, Mohamed Hsairi, Kamel Boukef, Ahlem Amouri, Hechmi Louzir, Koussay Dellagi, Abdeladhim Ben Abdeladhim
Journal: Blood
Blood (2006) 108 (11): 59.
https://doi.org/10.1182/blood.V108.11.59.59
Published: 2006